98 related articles for article (PubMed ID: 12443769)
21. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
[TBL] [Abstract][Full Text] [Related]
22. A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours.
Yen WC; Prudente RY; Corpuz MR; Negro-Vilar A; Lamph WW
Br J Cancer; 2006 Mar; 94(5):654-60. PubMed ID: 16495926
[TBL] [Abstract][Full Text] [Related]
23. Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.
Atigadda VR; Xia G; Desphande A; Boerma LJ; Lobo-Ruppert S; Grubbs CJ; Smith CD; Brouillette WJ; Muccio DD
J Med Chem; 2014 Jun; 57(12):5370-80. PubMed ID: 24801499
[TBL] [Abstract][Full Text] [Related]
24. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
[TBL] [Abstract][Full Text] [Related]
25. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma.
Yen WC; Prudente RY; Lamph WW
Breast Cancer Res Treat; 2004 Nov; 88(2):141-8. PubMed ID: 15564797
[TBL] [Abstract][Full Text] [Related]
26. Links between pharmacological properties of retinoids and nuclear retinoid receptors.
Bollag W; Isnardi L; Jablonska S; Klaus M; Majewski S; Pirson W; Toma S
Int J Cancer; 1997 Feb; 70(4):470-2. PubMed ID: 9033657
[No Abstract] [Full Text] [Related]
27. Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.
Ying SX; Seal S; Abbassi N; Hockenbery DM; Kiem HP; Li X; Pagel JM; Gopal AK; Deeg HJ
Leuk Lymphoma; 2007 May; 48(5):1003-14. PubMed ID: 17487744
[TBL] [Abstract][Full Text] [Related]
28. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
[TBL] [Abstract][Full Text] [Related]
29. [Studies on the structure-activity relationship of retinoids--Hansch analysis and 3D-OSAR studies on specific ligands of retinoid x receptor].
Huang N; Chu F; Guo Z
Yao Xue Xue Bao; 1998 Jun; 33(6):442-8. PubMed ID: 12016914
[TBL] [Abstract][Full Text] [Related]
30. Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions.
Takahashi B; Ohta K; Kawachi E; Fukasawa H; Hashimoto Y; Kagechika H
J Med Chem; 2002 Aug; 45(16):3327-30. PubMed ID: 12139443
[TBL] [Abstract][Full Text] [Related]
31. Identification of a retinoic acid receptor alpha subtype specific agonist.
Teng M; Duong TT; Klein ES; Pino ME; Chandraratna RA
J Med Chem; 1996 Aug; 39(16):3035-8. PubMed ID: 8759622
[No Abstract] [Full Text] [Related]
32. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases.
Gianni M; Ponzanelli I; Mologni L; Reichert U; Rambaldi A; Terao M; Garattini E
Cell Death Differ; 2000 May; 7(5):447-60. PubMed ID: 10800078
[TBL] [Abstract][Full Text] [Related]
33. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
34. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
Rigas JR; Dragnev KH
Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250
[TBL] [Abstract][Full Text] [Related]
35. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
[TBL] [Abstract][Full Text] [Related]
36. The influence of bexarotene, a selective agonist of the retinoid receptor X (RXR), and tazarotene, a selective agonist of the retinoid acid receptor (RAR), on bone metabolism in rats.
Nowak B; Matuszewska A; Filipiak J; Nikodem A; Merwid-Ląd A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A
Adv Med Sci; 2016 Mar; 61(1):85-9. PubMed ID: 26569440
[TBL] [Abstract][Full Text] [Related]
37. The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells.
Zhang C; Ni X; Konopleva M; Andreeff M; Duvic M
J Invest Dermatol; 2004 Aug; 123(2):380-7. PubMed ID: 15245439
[TBL] [Abstract][Full Text] [Related]
38. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA
Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
40. Rexinoids may be ready for prime time in prevention, but challenges remain.
Hede K
J Natl Cancer Inst; 2004 Dec; 96(24):1807-8. PubMed ID: 15601633
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
